Rocca, MA; Comi, G; Carra, A; Fazekas, F; Rieckmann, P; Bajenaru, O; Hillert, J; Elovaara, I; Young, C; Wynn, D; King, J; Lubetzki, C; Hartung, HP; Myhr KM; Espeyo, C; Komoly, S; Filippi, M; for the PreCISe study group.
Treatment with glatiramer acetate reduces T1 and T2-weighted magnetic resonance imaging activity in patients with clinically isplated syndrome suggestive of multiple sclerosis.
Multiple Sclerosis2008; 14(S1):S176-S176.-World Congress on Treatment and Research in Multiple Sclerosis: ACTRIMS + ECTRIMS + LACTRIMS; SEP 17-20, 2008; Montreal, CANADA.
[Poster]
Web of Science